Biologics such as antitumor necrosis factor (anti-TNF) drugs have emerged as important
agents in the treatment of many chronic inflammatory diseases, especially in cases …

Autoimmune diseases have long been known to share a common pathogenesis involving a
dysregulated immune system with a failure to recognize self from non-self-antigens. This …

Background Ustekinumab is currently approved globally in Crohn's disease (CD) and
psoriatic diseases. Recent phase 3 data demonstrate safety/efficacy in ulcerative colitis …

Despite multiple studies, the role of cytomegalovirus [CMV] infection in exacerbating the
severity of inflammation in ulcerative colitis [UC], and its response to treatment, remain …

Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease
(CD), is a multifactorial disease in which dietary, genetic, immunological, and microbial …

Background The association between ulcerative colitis and cytomegalovirus (CMV) has
been recognised for over 50 years; and the role of CMV in ulcerative colitis in general, and …

The link between cytomegalovirus (CMV) infection and inflammatory bowel diseases
remains an important subject of debate. CMV infection is frequent in ulcerative colitis (UC) …

Background & Aims Cytomegalovirus (CMV) is an opportunistic pathogen; documented
tissue involvement of patients with inflammatory bowel disease (IBD) is associated with …

Background The role of antiviral therapy in patients with ulcerative colitis (UC) with
cytomegalovirus (CMV) remains unclear. We therefore performed a systematic review and …

AIM: To identify definitions of cytomegalovirus (CMV) infection and intestinal disease, in
inflammatory bowel disease (IBD), to determine the prevalence associated with these …